The Goldman Sachs Group lowered shares of Taisho Pharmaceutical (OTCMKTS:TAIPY) from a neutral rating to a sell rating in a research note released on Monday, The Fly reports.
Shares of TAIPY stock opened at $16.87 on Monday. Taisho Pharmaceutical has a 1 year low of $12.11 and a 1 year high of $19.40. The business’s fifty day moving average is $16.40 and its 200-day moving average is $15.63.
Taisho Pharmaceutical Company Profile
Further Reading: Forex
Receive News & Ratings for Taisho Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Taisho Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.